Crossmark

The effect of SGLT2 inhibitors on hepatic steatosis detected by MRI-PDFF in patients with type 2 Diabetes mellitus and metabolic-associated steatotic liver disease: comment

Crossref DOI link: https://doi.org/10.1007/s11739-025-04024-z

Published Online: 2025-06-17

Published Print: 2025-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Di Vincenzo, Angelo https://orcid.org/0000-0002-7678-5671
Capone, Federico

Rossato, Marco
License Information

Text and Data Mining valid from 2025-06-17

Version of Record valid from 2025-06-17
More Information

Article History

Received: 10 June 2025

Accepted: 11 June 2025

First Online: 17 June 2025

Declarations

:

: There are no conflicts of interest related to this article.

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below